Isolate Data
| Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
| 260Pt14 | 260Pt14BC | U.S. | 1995 | HIV1 | B | PBMC | None |
Treatment History
| Order | Regimen | Weeks |
| 1 | AZT | NA |
RT Sequence
| NRTIMajorDRMs | NRTIMinorDRMs | NNRTIMajorDRMs | NNRTIMinorDRMs | Polys | UnusualMuts |
| D67N, K70R | K219Q | T69TN, K103R, Q174X, G196E, Q207R, F214L |
| >260Pt14BC| codons 26-245 LTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKNSNRWRKLVDFRELNKRTQ DFWEVQLGIPHPAGLKKRKSVTVLDVGDAYFSVPLDKDFRKYTAFTIPSINNETPGIRYQ YNVLPQGWKGSPAIFQSSMTKILEPFRKXNPDIVIYQYMDDLYVGSDLEIEQHRTKIEEL RRHLLRWGLTTPDQKHQKEPPFLWMGYELHPDKWTVQPIV |
References
| Author | Title | Citation |
| Demeter, LM | Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type I isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260). | AAC, 2000 |
| Gonzales, MJ | Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors. | AIDS, 2003 |
| Rhee, SY | HIV-1 Protease and Reverse Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance. | J Infect Dis, 2005 |